Nyberg J, Anderson MF, Meister B et al (2005) Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation
July 21, 2025
There is no placebo control, no blinding, and no standardized weight measurement protocol
The SURPASS clinical trials demonstrated that individuals with type 2 diabetes experienced substantial weight reductions while simultaneously getting their blood sugar under control
Others want enhanced formulations with glycine and B12
Moreover, in subjects with diabetes who were at high risk of cardiovascular events, treatment with GLP-1R agonists based on the structure of endogenous GLP-1, namely liraglutide, semaglutide, albiglutide, and dulaglutide, has demonstrated reductions in major adverse cardiovascular events (MACEs) that appear to be unrelated to the glycemic effects of these agents (1316)